Astellas Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of G...(community. Julie donates time tutoring t...)

Date:9/22/2009

community. Julie donates time tutoring, teaching religion and volunteering with a local youth group. She has also made more than 25 quilts for children at Cincinnati Children's Hospital Medical Center, a four hour distance from her home, where she volunteers. To continue giving back, Julie is pursuing a degree in elementary education and wants to help children find a love for learning. She will also continue educating her community about the importance of organ donation.

Douglas Lampert, Jr., liver transplant recipient from St. Louis, MO

Douglas Lampert, Jr. received a liver transplant when he was only nine months old, and since then, he has dedicated his life to raising awareness about the importance of organ donation. As a child, he participated in the Transplant Olympics in Japan, where he was able to share his story with people from all over the world. This experience helped drive Douglas' interest in learning languages so that he could share his story even more broadly. As a college student, Douglas is currently studying French and German alongside his primary degree of psychology. He hopes to work in a hospital and apply his psychology degree to helping families through the process of organ donation and transplantation.

Astellas will continue to follow the story of these six winners and the direct impact they are making on their communities. For more information regarding the Astellas Transplant Scholars Awards or to read the winning essays, visit www.AstellasTransplant.com; for transplant resources and information on transplant events visit www.TransplantExperience.com or www.Facebook.com/DonateLi
'/>"/>

SOURCE Astellas Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC
2. Astellas Pharma US, Inc. and The International Transplant Nurses Society (ITNS) Collaborate on Content for Transplant Experience Program
3. Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
4. CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection
5. Astellas Launches Lexiscan(TM) (Regadenoson) Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging (MPI)
6. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
7. CV Therapeutics Statement on Unsolicited Proposal From Astellas
8. CV Therapeutics Board of Directors Rejects Astellas Unsolicited Proposal
9. CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas Tender Offer
10. CV Therapeutics Board of Directors Rejects Astellas Tender Offer
11. Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients